EUVIMEDEUVIMED entdecken
Crossref

Lilly’s Insulin Journey: Translating Science into Medicines

Ashish Garg, D. Bruce Baldwin, Steven R. Cottle, Thomas Hoeg-Jensen, Michael R. De Felippis, Jenny Y. Chien, Alborz Mahdavi

Molecular Pharmaceutics · 13.11.2026

DOI: 10.1021/acs.molpharmaceut.6c01085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 13.11.2026. Verfasst von Ashish Garg und 6 weiteren Autor:innen. Die Arbeit nennt 94 Literaturangaben. Gefördert von: Eli Lilly and Company.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eli Lilly and Company’s century-long leadership in insulin innovations stands as a testament to its pioneering role in translating science into life-saving medicines. From producing the world’s first commercial insulin in 1923 to developing rapid-acting prandial analogs and long-acting basal analogs, Lilly’s insulin portfolio reflects major advances in molecular design, formulation, and manufacturing. This article chronicles the evolution of insulin science and how mechanistic understanding, strategic innovation, and manufacturing excellence at Lilly have continually advanced diabetes care. Key eras, from early animal-sourced insulin and the recombinant DNA revolution through molecular engineering of insulin analogs and the development of once-weekly basal insulin, are highlighted alongside the core scientific questions that drove each innovation. Together, these advances illustrate how Lilly scientists have applied molecular and manufacturing innovation to transform insulin from a crude life-sustaining extract into a portfolio of purposefully engineered molecules.

Förderung

  • Eli Lilly and Company

Zitieren

APA

Garg, A., Baldwin, D. B., Cottle, S. R., Hoeg-Jensen, T., Felippis, M. R. D., Chien, J. Y., & Mahdavi, A. (2026). Lilly’s Insulin Journey: Translating Science into Medicines. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c01085

Vancouver

Garg A, Baldwin DB, Cottle SR, Hoeg-Jensen T, Felippis MRD, Chien JY, et al. Lilly’s Insulin Journey: Translating Science into Medicines. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.6c01085

BibTeX
@article{Garg2026,
  author = {Garg, Ashish and Baldwin, D. Bruce and Cottle, Steven R. and Hoeg-Jensen, Thomas and Felippis, Michael R. De and Chien, Jenny Y. and Mahdavi, Alborz},
  title = {Lilly’s Insulin Journey: Translating Science into Medicines},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.6c01085}
}
Kostenlos starten →